• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

银屑病治疗目标中皮肤完全清除的重要性:对患者报告结局的影响。

Importance of Complete Skin Clearance in Psoriasis as a Treatment Goal: Implications for Patient-Reported Outcomes.

出版信息

J Drugs Dermatol. 2020 May 1;19(5):487-492.

PMID:32484628
Abstract

Psoriasis is associated with physical, psychological, social, and economic burdens that lead to substantial impairment over a patient’s lifetime. It is important to understand how different skin clearance levels may relate to patient perceptions of psoriasis symptoms and health-related quality of life. Here, we highlight notable advantages to complete skin clearance relative to high levels of efficacy without complete skin clearance, including meaningful improvements in patient-reported signs and symptoms of psoriasis, a higher mean proportion of symptom-free days, and significant improvements in quality of life. We also review biologic therapies associated with high percentages of complete skin clearance and significant improvements in signs and symptoms of psoriasis, notably brodalumab. These therapies are likely to play important roles in the future treatment of moderate-to-severe psoriasis, given that improvement in quality of life is of significant value relative to biologics or other systemic therapies associated with lower rates of complete skin clearance. J Drugs Dermatol. 2020;19(5): doi:10.36849/JDD.2020.4957.

摘要

银屑病会给患者带来身体、心理、社会和经济等多方面负担,使其一生都深受其扰。了解不同的皮肤清除率如何与患者对银屑病症状和健康相关生活质量的认知相关,这一点很重要。在此,我们重点介绍了与无完全皮肤清除但具有高疗效相比,完全皮肤清除的显著优势,包括患者报告的银屑病症状和体征的显著改善、无病日比例的均值更高,以及生活质量的显著改善。我们还回顾了与银屑病症状和体征的显著改善相关的高比例完全皮肤清除率的生物疗法,特别是布罗达卢单抗。鉴于与较低完全皮肤清除率相关的生物制剂或其他全身治疗相比,改善生活质量具有重要价值,这些疗法可能在中重度银屑病的未来治疗中发挥重要作用。J 皮肤病药物治疗杂志。2020;19(5):doi:10.36849/JDD.2020.4957.

相似文献

1
Importance of Complete Skin Clearance in Psoriasis as a Treatment Goal: Implications for Patient-Reported Outcomes.银屑病治疗目标中皮肤完全清除的重要性:对患者报告结局的影响。
J Drugs Dermatol. 2020 May 1;19(5):487-492.
2
Concept of Remission in Chronic Plaque Psoriasis.慢性斑块状银屑病的缓解概念。
J Rheumatol Suppl. 2015 Nov;93:57-60. doi: 10.3899/jrheum.150638.
3
Efficacy, Safety, and Patient-Reported Outcomes in Patients with Moderate-to-Severe Plaque Psoriasis Treated with Brodalumab for 5 Years in a Long-Term, Open-Label, Phase II Study.在一项长期、开放标签、2 期研究中,接受布罗达卢单抗治疗 5 年的中重度斑块状银屑病患者的疗效、安全性和患者报告结局。
Am J Clin Dermatol. 2019 Dec;20(6):863-871. doi: 10.1007/s40257-019-00466-2.
4
The New Psoriasis Paradigm: Striving for Complete Clearance.新的银屑病模式:追求完全清除。
J Drugs Dermatol. 2020 Jun 1;19(6):652-656. doi: 10.36849/JDD.2020.10.36849/JDD.2020.4975.
5
Onset of Plaque Psoriasis Treatment Responses With Anti-IL-17/IL-23 Biologic Therapies.抗 IL-17/IL-23 生物疗法治疗斑块状银屑病的起效时间。
J Drugs Dermatol. 2022 Aug 1;21(8):854-860. doi: 10.36849/JDD.66791.
6
Speed of clinical improvement in the real-world setting from patient-reported Psoriasis Symptoms and Signs Diary: Secondary outcomes from the Psoriasis Study of Health Outcomes through 12 weeks.从患者报告的银屑病症状和体征日记看真实世界中的临床改善速度:12 周内银屑病健康结局研究的次要结局。
J Eur Acad Dermatol Venereol. 2023 Sep;37(9):1825-1840. doi: 10.1111/jdv.19161. Epub 2023 May 20.
7
Clinical meaningfulness of complete skin clearance in psoriasis.银屑病完全皮肤清除的临床意义。
J Am Acad Dermatol. 2016 Jul;75(1):77-82.e7. doi: 10.1016/j.jaad.2016.03.026. Epub 2016 May 17.
8
Factors associated with patient-reported importance of skin clearance among adults with psoriasis and atopic dermatitis.与成人银屑病和特应性皮炎患者报告的皮肤清除重要性相关的因素。
J Am Acad Dermatol. 2019 Oct;81(4):943-949. doi: 10.1016/j.jaad.2019.06.018. Epub 2019 Jun 13.
9
A Retrospective Review of Patients' Response to Biologic Therapy for Psoriasis.回顾性分析生物制剂治疗银屑病的患者应答情况。
J Drugs Dermatol. 2021 Apr 1;20(4):442-449. doi: 10.36849/JDD.2021.5823.
10
Long-Term Skin Clearance With Brodalumab in Patients With Psoriasis and Inadequate Response to Prior Biologics.生物制剂治疗应答不足的银屑病患者使用布罗达卢单抗的长期皮肤清除率。
J Drugs Dermatol. 2022 Apr 1;21(4):354-370. doi: 10.36849/JDD.6743.

引用本文的文献

1
Comparison of patient-reported outcomes in patients achieving complete versus near-complete skin clearance following Vunakizumab treatment: a post-hoc analysis of a phase III trial.布那西单抗治疗后实现完全与接近完全皮肤清除的患者的患者报告结局比较:一项III期试验的事后分析
Naunyn Schmiedebergs Arch Pharmacol. 2025 Aug 25. doi: 10.1007/s00210-025-04490-4.
2
Brodalumab for Plaque Psoriasis in the Canadian Real-World Setting: A Retrospective Cohort Analysis of up to 4 Years.加拿大真实世界环境中布罗达单抗治疗斑块状银屑病:长达4年的回顾性队列分析
Dermatol Ther (Heidelb). 2025 Apr;15(4):949-962. doi: 10.1007/s13555-025-01369-3. Epub 2025 Mar 18.
3
Complete Skin Clearance is Associated with the Greatest Benefits to Health-Related Quality of Life and Perceived Symptoms for Patients with Psoriasis.
完全清除皮损对银屑病患者的健康相关生活质量和自觉症状具有最大益处。
Dermatol Ther (Heidelb). 2024 Oct;14(10):2841-2857. doi: 10.1007/s13555-024-01261-6. Epub 2024 Sep 17.
4
Impact of Disease Burden of Patients with Psoriasis on Biologic Therapy Switching: Real-World Evidence from the CorEvitas Psoriasis Registry.银屑病患者疾病负担对生物制剂治疗转换的影响:来自CorEvitas银屑病登记处的真实世界证据
Dermatol Ther (Heidelb). 2024 Oct;14(10):2787-2804. doi: 10.1007/s13555-024-01257-2. Epub 2024 Sep 16.
5
Skin Clearance is Associated with Reduced Treatment Failure in Patients with Psoriasis: Real-World Evidence from the CorEvitas Psoriasis Registry.皮肤清除与银屑病患者治疗失败率降低相关:来自CorEvitas银屑病登记处的真实世界证据。
Dermatol Ther (Heidelb). 2023 Nov;13(11):2739-2751. doi: 10.1007/s13555-023-01027-6. Epub 2023 Sep 27.
6
Patient-Reported Outcome Measures and Their Clinical Applications in Dermatology.患者报告结局测量及其在皮肤病学中的临床应用。
Am J Clin Dermatol. 2023 Jul;24(4):499-511. doi: 10.1007/s40257-023-00758-8. Epub 2023 Feb 1.
7
The impact of complete clearance and almost complete clearance of psoriasis on quality of life: a literature review.银屑病完全清除和几乎完全清除对生活质量的影响:一项文献综述
Arch Dermatol Res. 2023 May;315(4):699-706. doi: 10.1007/s00403-022-02420-5. Epub 2022 Nov 6.
8
Design and implementation of a mobile app for the pharmacotherapeutic follow-up of patients diagnosed with immune-mediated inflammatory diseases: eMidCare.用于诊断患有免疫介导的炎症性疾病的患者药物治疗随访的移动应用程序的设计与实现:eMidCare。
Front Immunol. 2022 Jul 28;13:915578. doi: 10.3389/fimmu.2022.915578. eCollection 2022.
9
Simultaneous Nail and Skin Clearance in Ixekizumab Head-to-Head Trials for Moderate-to-Severe Psoriasis and Psoriatic Arthritis.在中度至重度银屑病和银屑病关节炎的司库奇尤单抗头对头试验中指甲和皮肤同时清除。
Dermatol Ther (Heidelb). 2022 Apr;12(4):911-920. doi: 10.1007/s13555-022-00704-2. Epub 2022 Mar 13.